BiotechTube
Biofidus

Biofidus

Munich, Germany· Est.
biofidus.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Biofidus AG is a private, revenue-generating contract research organization (CRO) headquartered in Bielefeld, Germany, with a significant operational presence in Munich. The company provides a full suite of analytical services focused on the characterization of New Biological Entities (NBEs) and biosimilars, serving over 300 clients across 30+ countries. Following a merger with Midas Pharma, Biofidus combines deep analytical expertise with enhanced regulatory and commercialization capabilities, positioning itself as a one-stop partner for de-risking biopharmaceutical development. Its business model is purely service-based, operating in the Diagnostics, AI/Machine Learning, and Proteomics sectors as an analytical powerhouse.

DiagnosticsAI / Machine LearningProteomics

Technology Platform

Integrated bioanalytical platform combining mass spectrometric, cell-based, chromatographic, and sequencing assays for comprehensive structural and functional characterization of biologics and small molecules.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The growing complexity of biologic drug modalities (e.g., ADCs, multispecifics) and the regulatory emphasis on analytical comparability for biosimilars create strong demand for deep characterization services.
The merger with Midas Pharma expands the offering to include full regulatory and commercialization support, allowing Biofidus to capture more value across the client's product lifecycle and transition from a service provider to a strategic development partner.

Risk Factors

Revenue is tied to client R&D budgets, making it susceptible to biopharma industry downturns.
The CRO market is highly competitive, with pressure from large global players and niche specialists.
Operational risks include maintaining stringent quality standards, regulatory compliance, and retaining specialized scientific talent in a competitive labor market.

Competitive Landscape

Biofidus competes in the fragmented global bioanalytical CRO market against large, full-service CROs (e.g., LabCorp, IQVIA), specialized analytical service providers, and in-house pharma capabilities. Its differentiation lies in its deep focus on complex biologics characterization, a holistic 'one-stop' service model post-merger, and a client-centric partnership approach, targeting primarily biotech and pharma companies developing NBEs and biosimilars.

More companies in Diagnostics & Precision Medicine →More companies in Germany →